Kevin B. Yankton - Nov 16, 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Accounting Officer
Signature
/s/ William Solis, Attorney-in-Fact for Kevin B. Yankton
Stock symbol
TWST
Transactions as of
Nov 16, 2021
Transactions value $
$0
Form type
4
Date filed
11/30/2021, 03:35 PM
Previous filing
Aug 9, 2021
Next filing
Dec 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +1.6K +99.94% $0.00 3.2K Nov 16, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TWST Employee Stock Option (right to buy) Award $0 +2.55K $0.00 2.55K Nov 16, 2021 Common Stock 2.55K $115.99 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award ("RSU") of which 25% of the total number of RSUs vest on the first anniversary of May 17, 2021 and 1/16th of the total number of RSUs vest on each quarterly anniversary thereafter, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.
F2 25% of the shares subject to the option vest and become exercisable on the one (1) year anniversary of May 17, 2021 and 1/48 of the shares subject to the option vest and become exercisable monthly thereafter, subject to the Reporting Person's continuous service through each vesting date.